Flat, non-polypoid colorectal neoplasms (NP-CRNs), which may be difficult to detect, appear to be relatively common and may have a greater association with cancer compared with the more routinely diagnosed type of colorectal polyps, according to a ...

Oregon Health & Science University researchers have received more than $370,000 in grants to study whether a drug typically used to prevent alcoholism relapses can also be used to treat tinnitus. Approximately 14 percent to 20 percent of the U.S. ...

One of the world’s pre-eminent experts in urogynecology at Oregon Health & Science University has received $1.2 million in grants from the National Institutes of Health to study the extent of pelvic floor injury in women before, during and after ...

Oregon Health & Science University Cancer Institute researchers, in a first-of-its-kind study, have found that even men with advanced prostate cancer can take a much-needed safe break, or holiday, from chemotherapy. The double-blind, randomized study, ...

Research conducted at Oregon Health & Science University and other sites around the globe demonstrates that a new stroke therapy is highly successful in removing blood clots blocking arteries in the brains of stroke patients. OHSU’s Oregon Stroke ...

In a newly released study it was found that when parents from low-income families succeed in pulling themselves out of poverty and gaining employment with private health insurance, their kids are sometimes left uninsured. “It was surprising to also ...

Researchers at Oregon Health & Science University who played a critical role in the development of Gleevec - the revolutionary pill that has given more than 100,000 cancer patients the gift of longer life - are now getting a special gift of their own: ...

An Oregon Health & Science University Cancer Institute researcher has found a biomarker that may help improve the ability to predict if a man's prostate cancer is going to come back after surgical removal. In order to make this discovery, researchers ...

Najít Technologies Inc., an Oregon Health & Science University spinoff company has been awarded a $1.65 million grant from the National Institutes of Health to develop diagnostic tests that will help detect suspected bioterrorist attacks. Mark Slifka, ...

Selective publication in reporting results of antidepressant trials exaggerates the effectiveness of the drugs, according to a report in the January 17 issue of the New England Journal of Medicine. The report’s primary author is Erick Turner, M.D., ...